Abstract
Gout, a common type of inflammatory arthritis resulting from chronic elevation of uric acid (UA) level, is usually accompanied with hyperuricemia. The current clinical drugs for the treatment of gout and hyperuricemia are greatly restricted by their limited therapeutic efficacy, off-target toxicity and severe side effects. Here, a neutrophil membrane (NM)-coated and cascade catalytic nanoenzyme was devised with excellent inflammation targeting, inflammatory cytokines neutralizing and UA degrading characteristics for the treatment of gout and hyperuricemia with high efficacy and safety. This nanoenzyme was fabricated by encapsulating uricase (UOx) and catalase (CAT) into zeolitic imidazolate framework-8 (ZIF-8) and further coating it with NM. The NM-coated nanoenzyme inherits the antigenic exterior and cell membrane functions of neutrophils for inflammation targeting and cytokine neutralization. UOx and CAT encapsulated in ZIF-8 could efficiently degrade UA and eliminate hydrogen peroxide (H2O2) via a biocatalytic cascade, thus successfully blocking the inflammation amplification during gout development. Both in vitro and in vivo experiments demonstrated the preferable potentials of the nanoenzyme for gout targeting, inflammation elimination and UA degradation, exhibiting great promise for the treatment of gout and hyperuricemia in an effective and safe manner.
Similar content being viewed by others
References
Rouault TA. Nat Rev Neurosci, 2013, 14: 551–564
Samadi M, Moradi S, Moradinazar M, Mostafai R, Pasdar Y. Neurol Sci, 2019, 40: 2031–2043
Lan G, Zhang J, Ye W, Yang F, Li A, He W, Zhang WD. Sci China Chem, 2019, 62: 409–416
Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Int J Cardiol, 2016, 213: 8–14
Borghi C, Palazzuoli A, Landolfo M, Cosentino E. Heart Fail Rev, 2020, 25: 43–51
Schroder K, Zhou R, Tschopp J. Science, 2010, 327: 296–300
Raucci F, Iqbal AJ, Saviano A, Minosi P, Piccolo M, Irace C, Caso F, Scarpa R, Pieretti S, Mascolo N, Maione F. Pharmacol Res, 2019, 147: 104351
Schauer C, Janko C, Munoz LE, Zhao Y, Kienhöfer D, Frey B, Lell M, Manger B, Rech J, Naschberger E, Holmdahl R, Krenn V, Harrer T, Jeremic I, Bilyy R, Schett G, Hoffmann M, Herrmann M. Nat Med, 2014, 20: 511–517
Martinon F, Mayor A, Tschopp J. Annu Rev Immunol, 2009, 27: 229–265
Richette P, Clerson P, Périssin L, Flipo RM, Bardin T. Ann Rheum Dis, 2015, 74: 142–147
Rock KL, Kataoka H, Lai JJ. Nat Rev Rheumatol, 2013, 9: 13–23
Bardin T, Richette P. BMC Med, 2017, 15: 123
Dehlin M, Jacobsson L, Roddy E. Nat Rev Rheumatol, 2020, 16: 380–390
Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F. Arthritis Rheum, 2008, 58: 26–35
Kuo CF, Grainge MJ, Zhang W, Doherty M. Nat Rev Rheumatol, 2015, 11: 649–662
Pillinger M H, Mandell B F. Nat Rev Rheumatol, 2020, 50: S24–S30
van Durme CM, Wechalekar MD, Buchbinder R, Schlesinger N, van der Heijde D, Landewé RB. Cochrane Database Syst Rev, 2014, 9: Cd010120
Dalbeth N, Lauterio TJ, Wolfe HR. Clin Ther, 2014, 36: 1465–1479
Johnson RJ, Choi HK, Yeo AE, Lipsky PE. Hypertension, 2019, 74: 95–101
Perez-Ruiz F, Dalbeth N. Seminars Arthritis Rheumatism, 2019, 48: 658–668
Bardin T, Keenan RT, Khanna PP, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, So A. Ann Rheum Dis, 2017, 76: 811–820
Aung T, Myung G, FitzGerald J. PPA, 2017, 11: 795–800
Huang Y, Zhang C, Xu Z, Shen J, Zhang X, Du H, Zhang K, Zhang D. Hellenic J Cardiol, 2017, 58: 360–365
Liu Y, Du J, Yan M, Lau MY, Hu J, Han H, Yang OO, Liang S, Wei W, Wang H, Li J, Zhu X, Shi L, Chen W, Ji C, Lu Y. Nat Nanotech, 2013, 8: 187–192
Xu D, Han H, He Y, Lee H, Wu D, Liu F, Liu X, Liu Y, Lu Y, Ji C. Adv Mater, 2018, 30: 1707443
Li H, Li L, Wang X, Li Q, Du M, Tang B. Sci China Chem, 2015, 58: 825–829
Singh JA. J Clin Rheumatol, 2014, 20: 172–174
Keith MP, Gilliland WR. Am J Med, 2007, 120: 221–224
Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Nature, 2006, 440: 237–241
Brovold H, Lund T, Svistounov D, Solbu MD, Jenssen TG, Ytrehus K, Zykova SN. Sci Rep, 2019, 9: 10513
Phillipson M, Kubes P. Nat Med, 2011, 17: 1381–1390
Kolaczkowska E, Kubes P. Nat Rev Immunol, 2013, 13: 159–175
Xue J, Zhao Z, Zhang L, Xue L, Shen S, Wen Y, Wei Z, Wang L, Kong L, Sun H, Ping Q, Mo R, Zhang C. Nat Nanotech, 2017, 12: 692–700
Chu D, Dong X, Shi X, Zhang C, Wang Z. Adv Mater, 2018, 30: 1706245
Popa-Nita O, Naccache PH. Immunol Cell Biol, 2010, 88: 32–40
Schorn C, Strysio M, Janko C, Munoz LE, Schett G, Herrmann M. Autoimmunity, 2010, 43: 236–238
Yang X, Li J, Yu Y, Wang J, Li D, Cao Z, Yang X. Sci China Chem, 2019, 62: 1379–1386
Guo W, Liu L, Xiang C, Chen J, Liang XJ. Sci China Chem, 2019, 62: 1557–1560
Sun M, Qian Q, Shi L, Xu L, Liu Q, Zhou L, Zhu X, Yue JM, Yan D. Sci China Chem, 2020, 63: 35–41
Kang T, Zhu Q, Wei D, Feng J, Yao J, Jiang T, Song Q, Wei X, Chen H, Gao X, Chen J. ACS Nano, 2017, 11: 1397–1411
Zhang C, Zhang L, Wu W, Gao F, Li R, Song W, Zhuang Z, Liu C, Zhang X. Adv Mater, 2019, 31: 1901179
Zhang Q, Dehaini D, Zhang Y, Zhou J, Chen X, Zhang L, Fang RH, Gao W, Zhang L. Nat Nanotech, 2018, 13: 1182–1190
Gao LZ, Wei H, Qu XG. Sin Vitae, 2020, 50: 682–697
Huang Y, Ren J, Qu X. Chem Rev, 2019, 119: 4357–4412
Jiang D, Ni D, Rosenkrans Z, Huang P, Yan X, Cai W. Chem Soc Rev, 2019, 48: 3683–3704
Zhang L, Wan SS, Li CX, Xu L, Cheng H, Zhang XZ. Nano Lett, 2018, 18: 7609–7618
Liu W, Liu T, Zou M, Yu W, Li C, He Z, Zhang M, Liu M, Li Z, Feng J, Zhang X. Adv Mater, 2018, 30: 1802006
Zhang Z, Gu Y, Liu Q, Zheng C, Xu L, An Y, Jin X, Liu Y, Shi L. Small, 2018, 14: 1801865
Liu X, Zhang Z, Zhang Y, Guan Y, Liu Z, Ren J, Qu X. Adv Funct Mater, 2016, 26: 7921–7928
Li X, Xu D, Sun D, Zhang T, He X, Xiao D. J Cell Biochem, 2019, 120: 6718–6728
Cheng H, Zhu JY, Li SY, Zeng JY, Lei Q, Chen KW, Zhang C, Zhang XZ. Adv Funct Mater, 2016, 26: 7847–7860
Zarbock A, Ley K, McEver RP, Hidalgo A. Blood, 2011, 118: 6743–6751
Busso N, So A. Arthritis Res Ther, 2010, 12: 206
So AK, Martinon F. Nat Rev Rheumatol, 2017, 13: 639–647
Mitroulis I, Kambas K, Ritis K. Semin Immunopathol, 2013, 35: 501–512
Zhuang J, Duan Y, Zhang Q, Gao W, Li S, Fang RH, Zhang L. Nano Lett, 2020, 20: 4051–4058
Wang Y, Zhang K, Qin X, Li T, Qiu J, Yin T, Huang J, McGinty S, Pontrelli G, Ren J, Wang Q, Wu W, Wang G. Adv Sci, 2019, 6: 1900172
Wei X, Ying M, Dehaini D, Su Y, Kroll AV, Zhou J, Gao W, Fang RH, Chien S, Zhang L. ACS Nano, 2018, 12: 109–116
Acknowledgements
This work was supported by the National Natural Science Foundation of China (51833007, 51690152, 51988102, 21721005).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Zhang, L., Zhang, C., Zhuang, ZN. et al. Bio-inspired nanoenzyme for metabolic reprogramming and anti-inflammatory treatment of hyperuricemia and gout. Sci. China Chem. 64, 616–628 (2021). https://doi.org/10.1007/s11426-020-9923-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-020-9923-9